New vaccine aims to turbocharge TB recovery, fight drug resistance
NCT ID NCT05455112
Summary
This study tested if adding an experimental vaccine called RUTI to the standard antibiotic treatment for tuberculosis (TB) helps patients get better faster. The vaccine is designed to boost the body's immune response to help kill TB bacteria, especially those that are hard for drugs to reach. Researchers enrolled 41 adults with active lung TB to see if the combination was safe and could speed up recovery without increasing the risk of the bacteria becoming drug-resistant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS, PULMONARY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital José Nestor Lencinas
Godoy Cruz, Mendoza Province, M5547, Argentina
-
Hospital de Clínicas Presidente Dr. Nicolás Avellaneda
San Miguel de Tucumán, Tucumán Province, T4001KKP, Argentina
Conditions
Explore the condition pages connected to this study.